BioXcel Therapeutics Statistics

Total Valuation

BTAI has a market cap or net worth of $6.58 million. The enterprise value is $71.16 million.

Market Cap	6.58M
Enterprise Value	71.16M

Important Dates

The last earnings date was Thursday, March 27, 2025, before market open.

Earnings Date	Mar 27, 2025
Ex-Dividend Date	n/a

Share Statistics

BTAI has 3.10 million shares outstanding. The number of shares has increased by 39.24% in one year.

Current Share Class	3.10M
Shares Outstanding	3.10M
Shares Change (YoY)	+39.24%
Shares Change (QoQ)	+14.71%
Owned by Insiders (%)	1.04%
Owned by Institutions (%)	9.17%
Float	2.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.37
Forward PS	1.97
PB Ratio	-0.08
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	31.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-126.15%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$30,622
Profits Per Employee	-$805,392
Employee Count	74
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.40% in the last 52 weeks. The beta is 0.90, so BTAI's price volatility has been lower than the market average.

Beta (5Y)	0.90
52-Week Price Change	-95.40%
50-Day Moving Average	3.26
200-Day Moving Average	9.42
Relative Strength Index (RSI)	41.20
Average Volume (20 Days)	8,650,789

Short Selling Information

The latest short interest is 221,319, so 7.14% of the outstanding shares have been sold short.

Short Interest	221,319
Short Previous Month	330,479
Short % of Shares Out	7.14%
Short % of Float	9.72%
Short Ratio (days to cover)	0.02

Income Statement

In the last 12 months, BTAI had revenue of $2.27 million and -$59.60 million in losses. Loss per share was -$23.51.

Revenue	2.27M
Gross Profit	123,000
Operating Income	-64.80M
Pretax Income	n/a
Net Income	-59.60M
EBITDA	-64.49M
EBIT	-64.80M
Loss Per Share	-$23.51

Full Income Statement

Balance Sheet

The company has $40.39 million in cash and $104.97 million in debt, giving a net cash position of -$64.58 million or -$20.82 per share.

Cash & Cash Equivalents	40.39M
Total Debt	104.97M
Net Cash	-64.58M
Net Cash Per Share	-$20.82
Equity (Book Value)	-85.63M
Book Value Per Share	-32.27
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	5.43%
Operating Margin	-2,859.84%
Pretax Margin	-2,630.14%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-39.24%
Shareholder Yield	n/a
Earnings Yield	-906.33%
FCF Yield	n/a

Analyst Forecast

The average price target for BTAI is $42.60, which is 1,909.43% higher than the current price. The consensus rating is "Buy".

Price Target	$42.60
Price Target Difference	1,909.43%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	122.95%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 10, 2025. It was a reverse split with a ratio of 0.0625:1.

Last Split Date	Feb 10, 2025
Split Type	Reverse
Split Ratio	0.0625:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a